Condition: Long-COVID · Long COVID-19 · Post-COVID-19 Syndrome · Sponsor: Lawson Research Institute of St. Joseph's
Long COVID is a complex condition that affects approximately 1.4 million Canadians following SARS-CoV-2 infection. Fatigue is the most common symptom of Long COVID. This feasibility trial will evaluate a new rehabilitation program called COVIDEx for treating fatigue after COVID-19, and compare its effectiveness to the standard treatment currently used. The experimental treatment group will receive an 8-week multi-modal rehabilitation program with two 50-minute sessions per week. 60 participants will be recruited, randomly assigned to the COVIDEx program or standard of care (SoC) and followed for 24 weeks.
This description comes directly from the study's public registry record.
Nicole Billias, BPH, CPT · 519-646-6100 · Nicole.Billias@sjhc.london.on.ca
Arden Lawson, BMSc · 519-646-6100 · Arden.Lawson@sjhc.london.on.ca
Always discuss trial participation with your own doctor first.
| Parkwood Hospital - St. Joseph's Health Care London | London, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06156176